1. Signaling Pathways
  2. NF-κB
  3. NF-κB

NF-κB (核因子κB)

Nuclear factor-κB; Nuclear factor-kappaB

NF-κB(活化 B 细胞的核因子 κ 轻链增强子)是一种控制 DNA 转录的蛋白质复合物。NF-κB 存在于几乎所有动物细胞类型中,并参与细胞对压力、细胞因子、自由基、紫外线照射、氧化 LDL 以及细菌或病毒抗原等刺激的反应。NF-κB 在调节对感染的免疫反应中起着关键作用。NF-κB 的错误调节与癌症、炎症和自身免疫性疾病、感染性休克、病毒感染和免疫发育不当有关。NF-κB 还与突触可塑性和记忆过程有关。哺乳动物 NF-κB 家族中有五种蛋白质:NF-κB1、NF-κB2、RelA、RelB、c-Rel。

NF-κB (Nuclear factor kappa-light-chain-enhancer of activated B cells) is a protein complex that controls transcription of DNA. NF-κB is found in almost all animal cell types and is involved in cellular responses to stimuli such as stress, cytokines, free radicals, ultraviolet irradiation, oxidized LDL, and bacterial or viral antigens. NF-κB plays a key role in regulating the immune response to infection. Incorrect regulation of NF-κB has been linked to cancer, inflammatory, and autoimmune diseases, septic shock, viral infection, and improper immune development. NF-κB has also been implicated in processes of synaptic plasticity and memory. There are five proteins in the mammalian NF-κB family: NF-κB1, NF-κB2, RelA, RelB, c-Rel.

Cat. No. Product Name Effect Purity Chemical Structure
  • HY-B0898R
    Ceftiofur sodium (Standard)

    头孢噻呋钠 (Standard)

    Inhibitor
    Ceftiofur sodium (Standard) 是 Ceftiofur sodium (HY-B0898) 的分析标准品。本产品用于研究及分析应用。Ceftiofur sodium 是一种靶向细菌青霉素结合蛋白 (PBPs) 的细胞壁合成抑制剂,在内毒素血症中具有抗炎作用。Ceftiofur sodium 通过抑制细菌细胞壁肽聚糖的合成发挥杀菌作用,导致细菌细胞裂解。Ceftiofur sodium 还抑制 NF-κBMAPKs 的激活,从而减少 TNF-α、IL-1β 和 IL-6 等促炎细胞因子的分泌。
    Ceftiofur sodium (Standard)
  • HY-117726
    WAY-169916 Inhibitor 99.60%
    WAY-169916 是一种雌激素受体的途径选择性配体,通过抑制 NF-kB 转录活性发挥作用。WAY-169916 具有抗炎活性。
    WAY-169916
  • HY-135317B
    Emavusertib hydrochloride Inhibitor
    Emavusertib hydrochloride (CA-4948 tosylate) 是 Emavusertib (HY-135317) 的盐酸盐形式。Emavusertib hydrochloride 是口服有效的 IRAK4 (IC50=57 nM) 和 FLT3 抑制剂。Emavusertib hydrochloride 可抑制 NF-κBMyD88 信号通路,减少促炎细胞因子(如 IL-6 和 IL-10)的产生,从而表现出抗炎和对癌细胞的抗增殖活性,诱导细胞凋亡 (apoptosis)。Emavusertib hydrochloride 在小鼠模型中表现出抗肿瘤活性。
    Emavusertib hydrochloride
  • HY-N2908R
    Atraric acid (Standard) Inhibitor
    Atraric acid (Standard)是 Atraric acid 的分析标准品。本产品用于研究及分析应用。Atraric acid (Methyl atrarate) 是一种特异的雄激素受体 (androgen receptor) 拮抗剂,具有抗炎和抗癌作用。Atraric acid 抑制 LNCaP 和 C4-2 细胞中内源性前列腺特异性抗原基因的表达。Atraric acid 还能抑制 NO 和细胞因子的合成,抑制 MAPK-NFκB 信号通路。At
    Atraric acid (Standard)
  • HY-B2082R
    Fursultiamine (Standard)

    呋喃硫胺 (Standard)

    Inhibitor
    Fursultiamine (Standard)是 Fursultiamine 的分析标准品。本产品用于研究及分析应用。Fursultiamine 是一种维生素 B1 衍生物,具有抗伤害和抗肿瘤活性。Fursultiamine 可用于维生素 B1 缺乏病,骨关节炎 (OA) 和癌症研究。Fursultiamine 还能够减轻缺氧条件诱导的 VEGF 分泌和线粒体分裂。
    Fursultiamine (Standard)
  • HY-N0629R
    Maslinic acid (Standard)

    山楂酸 (Standard)

    Inhibitor
    Maslinic acid (Standard) 是 Maslinic acid 的分析标准品。本产品用于研究及分析应用。Maslinic acid 可抑制 NF-κB p65 的 DNA 结合活性, 并消除 IκB-α 磷酸化。
    Maslinic acid (Standard)
  • HY-N0738R
    Stachydrine hydrochloride (Standard)

    盐酸水苏碱 (Standard)

    Inhibitor
    Stachydrine hydrochloride (Standard) 是 Stachydrine hydrochloride 的分析标准品。本产品用于研究及分析应用。Stachydrine hydrochloride 是益母草的主要活性成分,可用于心血管疾病的研究。Stachydrine hydrochloride 可以抑制 NF-κB 信号通路。具有抗心肌肥大活性 。
    Stachydrine hydrochloride (Standard)
  • HY-14654A
    Aspirin lithium Inhibitor
    Aspirin (Acetylsalicylic Acid) lithium 是一种口服有效的不可逆的环氧合酶 COX-1COX-2 抑制剂,IC50 分别为 5 和 210 μg/mL. Aspirin lithium 诱导细胞凋亡 (apoptosis)。Aspirin lithium 可抑制 NF-κB 的活化。Aspirin lithium 还抑制血小板前列腺素合成酶 (prostaglandin synthetase),可预防冠状动脉和脑血管血栓形成。
    Aspirin lithium
  • HY-W062904
    Laquinimod sodium

    拉喹莫德钠盐

    Inhibitor
    Laquinimod (ABR-215062) sodium 是一种可口服的羧酰胺衍生物,是一种有效的免疫调节剂,可防止中枢神经系统的神经变性和炎症。Laquinimod sodium 减少星形胶质细胞 NF-κB 的活化以防止铜酮 (Cuprizone) 诱导的脱髓鞘。Laquinimod sodium 具有用于多发性硬化症 (MS;RRMS 或 CPMS) 的复发缓解 (RR) 和慢性进行性 (CP) 形式以及神经退行性疾病研究的潜力。
    Laquinimod sodium
  • HY-B0008A
    Sulindac sodium

    舒林酸(钠)

    Inhibitor
    Sulindac (MK-231) 是一种口服活性非甾体类抗炎药。 Sulindac 也是一种免疫调节剂。 Sulindac 可用于脊柱关节炎、痛风性关节炎及多种癌症如结直肠癌、肺癌的研究。
    Sulindac sodium
  • HY-144745
    HSR1304 Inhibitor
    HSR1304 (Compound 5d) 是一种有效的 NFκB 抑制剂。多功能转录因子核因子-κB (NF-κB) 广泛参与多种人类疾病,例如癌症和慢性炎症。HSR1304 具有研究癌症疾病的潜力。
    HSR1304
  • HY-100507A
    Avadomide hydrochloride Inhibitor
    Avadomide hydrochloride (CC 122 hydrochloride) 是 Avadomide (HY-100507) 的盐酸盐形式。Avadomide hydrochloride 是口服有效的 cereblon 调节剂。Avadomide hydrochloride 可以调节 cereblon E3 连接酶活性,抑制 NF-κB 通路,在 G1 期阻滞细胞周期,从而诱导癌细胞 PDAC 的细胞凋亡 (apoptosis)。Avadomide hydrochloride 具有抗肿瘤和免疫调节活性。
    Avadomide hydrochloride
  • HY-142119
    Penehyclidine

    戊乙奎醚

    Activator
    Penehyclidine 是一种抗胆碱能剂,选择性的 M1M3 受体拮抗剂。Penehyclidine 可激活肺组织中的 NF-kβ 并抑制炎症因子的释放。Penehyclidine 可减轻慢性阻塞性肺病 (COPD) 大鼠机械通气时的肺部炎症反应。
    Penehyclidine
  • HY-N0176S
    Dihydroartemisinin-d3

    双氢青蒿素 d3

    Inhibitor
    Dihydroartemisinin-d3 是 Dihydroartemisinin 的氘代物。Dihydroartemisinin是一种有效的抗疟疾 (anti-malaria) 活性分子。
    Dihydroartemisinin-d<sub>3</sub>
  • HY-P991475
    MG-1131 Activator
    MG-1131 是一种靶向 TIGIT 的人源单克隆抗体 (mAb)。MG-1131 激活 T 细胞中的 NF-κB 信号传导,并以 PVR 依赖性方式增强 NK 介导的肿瘤杀伤活性。MG-1131 阻断 TIGIT 导致 IFN-γ 分泌增加。MG-1131 可用于抗肿瘤免疫的研究。推荐同型对照:Human IgG1 kappa,Isotype Control (HY-P99001)。
    MG-1131
  • HY-139833
    Anti-inflammatory agent 6
    Anti-inflammatory agent 6 阻断作为炎症关键控制器的Iκb激酶α/β(IKKα/β)、IκBα 和核因子 kB p65(NF-κb p65)的磷酸化,从而显示出抗炎潜力。
    Anti-inflammatory agent 6
  • HY-W010270A
    Aurothiomalate disodium

    金硫丁二钠

    Inhibitor
    Aurothiomalate (disodium) 是一种 TRPA1 抑制剂。Aurothiomalate (disodium) 可抑制 NF-κB 活化和 iNOS 的表达。Aurothiomalate (disodium) 可促进巨噬细胞的 M2 转化,增加 TREM-2 和精氨酸酶-1 (arginase-1) 的表达。Aurothiomalate (disodium) 可用于肝纤维化/肝硬化和关节炎的研究。
    Aurothiomalate disodium
  • HY-128483R
    Fusaric acid (Standard)

    萎蔫酸 (Standard)

    Inhibitor
    Fusaric acid (Standard) 是 Fusaric acid (HY-128483) 的分析标准品。本产品用于研究及分析应用。Fusaric acid 是一种口服有效的多通路抑制剂,具有诱导氧化应激和凋亡 (apoptosis) 的活性。Fusaric acid 可螯合二价金属阳离子、损伤线粒体膜结构,激活 Caspase-3/7、-8、-9 等凋亡相关蛋白酶。Fusaric acid 还调节 Bax/Bcl-2 蛋白,抑制 NF-κBTGF-β1/SMADsPI3K/AKT/mTOR 等纤维化相关信号通路,减少胶原沉积。Fusaric acid 也是一种多巴胺 β-羟化酶 (dopamine β-hydroxylase) 抑制剂,可降低脑、心脏、脾脏和肾上腺中去甲肾上腺素和肾上腺素的内源性水平。Fusaric acid 可在心脏疾病中发挥心肌纤维化、改善心脏肥厚的作用,还能够用于食管癌、肝癌等研究。
    Fusaric acid (Standard)
  • HY-N8290R
    Lactupicrin (Standard) Inhibitor
    Lactupicrin (Standard) 是 Lactupicrin 的分析标准品。本产品用于研究及分析应用。Lactupicrin (Lactucopicrin) 具有镇痛、镇静、抗疟疾和保护动脉粥样硬化的作用。Lactupicrin 抑制 acetylcholinesterase (AChE)IC50 为 150.3 μM。Lactupicrin 是一种特有的苦味倍半萜内酯,具有口服活性。
    Lactupicrin (Standard)
  • HY-158311
    Anti-osteoporosis agent-8 Inhibitor
    Anti-osteoporosis agent-8 (Compound 4aa) 是 RANKL 抑制剂,可抑制 RANKL 诱导的破骨细胞生成和破骨细胞分化,IC50 为 2.41 μM。Anti-osteoporosis agent-8 可改善卵巢切除 (OVX) 小鼠模型中的骨质流失。
    Anti-osteoporosis agent-8
目录号 产品名 / 同用名 应用 反应物种

NF-κB transcription factors are critical regulators of immunity, stress responses, apoptosis and differentiation. In mammals, there are five members of the transcription factor NF-κB family: RELA (p65), RELB and c-REL, and the precursor proteins NF-κB1 (p105) and NF-κB2 (p100), which are processed into p50 and p52, respectively. NF-κB transcription factors bind as dimers to κB sites in promoters and enhancers of a variety of genes and induce or repress transcription. NF-κB activation occurs via two major signaling pathways: the canonical and the non-canonical NF-κB signaling pathways[1]

 

The canonical NF-κB pathway is triggered by signals from a large variety of immune receptors, such as TNFR, TLR, and IL-1R, which activate TAK1. TAK1 then activates IκB kinase (IKK) complex, composed of catalytic (IKKα and IKKβ) and regulatory (NEMO) subunits, via phosphorylation of IKKβ. Upon stimulation, the IKK complex, largely through IKKβ, phosphorylates members of the inhibitor of κB (IκB) family, such as IκBα and the IκB-like molecule p105, which sequester NF-κB members in the cytoplasm. IκBα associates with dimers of p50 and members of the REL family (RELA or c-REL), whereas p105 associates with p50 or REL (RELA or c-REL). Upon phosphorylation by IKK, IκBα and p105 are degradated in the proteasome, resulting in the nuclear translocation of canonical NF-κB family members, which bind to specific DNA elements, in the form of various dimeric complexes, including RELA-p50, c-REL-p50, and p50-p50. Atypical, IKK-independent pathways of NF-κB induction also provide mechanisms to integrate parallel signaling pathways to increase NF-κB activity, such as hypoxia, UV and genotoxic stress.

 

The non-canonical NF-κB pathway is induced by certain TNF superfamily members, such as CD40L, BAFF and lymphotoxin-β (LT-β), which stimulates the recruitment of TRAF2, TRAF3, cIAP1/2 to the receptor complex. Activated cIAP mediates K48 ubiquitylation and proteasomal degradation of TRAF3, resulting in stabilization and accumulation of the NFκB-inducing kinase (NIK). NIK phosphorylates and activates IKKα, which in turn phosphorylates p100, triggering p100 processing, and leading to the generation of p52 and the nuclear translocation of p52 and RELB[2][3].

 

Reference:

[1]. Oeckinghaus A, et al. The NF-kappaB family of transcription factors and its regulation.Cold Spring Harb Perspect Biol. 2009 Oct;1(4):a000034. 
[2]. Taniguchi K, et al. NF-κB, inflammation, immunity and cancer: coming of age. Nat Rev Immunol. 2018 May;18(5):309-324.
[3]. Perkins ND,et al. Integrating cell-signalling pathways with NF-kappaB and IKK function. Nat Rev Mol Cell Biol. 2007 Jan;8(1):49-62.

Your Search Returned No Results.

Sorry. There is currently no product that acts on isoform together.

Please try each isoform separately.